A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments
- Autori: R. Caorsi, A. Insalaco, F. Bovis, G. Martini, M. Cattalini, M. Chinali, A. Rimini, C. Longo, S. Federici, C. Celani, G. Filocamo, R. Consolini, M.C. Maggio, G. Fadanelli, F. Licciardi, M. Romano, B. Teruzzi, A. Taddio, A. Miniaci, F. La Torre, A. De Fanti, G. Cavalli, B. Bigucci, R. Gallizzi, M. Chinello, A. Brucato, M. Imazio, R. Cimaz, F. De Benedetti, M. Gattorno
- Anno di pubblicazione: 2020
- Tipologia: Abstract in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/464189
Abstract
Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.